Michael Millward
8PUBLICATIONS
83CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 02, 2026
A Phase 2 Study of Eribulin in Patients with Metastatic Angiosarcoma and Epithelioid Hemangioendothelioma.Gregory M Cote, Mason Aberoumand, Edwin Choy
|Aug 29, 2024
Patient Experience of Complex Genomic Sequencing Exploring Patient Preference, Barriers, and Enablers for Delivery.Kortnye Smith, Sophie O'Haire, Benjamin Markman
|Aug 05, 2024
Outcomes With Postrecurrence Systemic Therapy Following Adjuvant Checkpoint Inhibitor Treatment for Resected Melanoma in CheckMate 238.Jeffrey Weber, Michele Del Vecchio, Mario Mandalá
|Apr 14, 2023
Adjuvant Nivolumab versus Ipilimumab in Resected Stage III/IV Melanoma: 5-Year Efficacy and Biomarker Results from CheckMate 238.James Larkin, Michele Del Vecchio, Mario Mandalá
|Dec 21, 2021
Correction: Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.Jason D Lickliter, Mark Voskoboynik, Linda Mileshkin
|Nov 19, 2021
Phase 1A/1B dose-escalation and -expansion study to evaluate the safety, pharmacokinetics, food effects and antitumor activity of pamiparib in advanced solid tumours.Jason D Lickliter, Mark Voskoboynik, Linda Mileshkin
Pageof 2
Frequent Collaborators
2 joint publications
Helen Gogas
2 joint publications
Luis de la Cruz-Merino
2 joint publications
Vanna Chiarion-Sileni
2 joint publications
Michael Schenker
2 joint publications
Marcus O Butler
2 joint publications
Mario Mandalá
2 joint publications
Ivan Marquez-Rodas
2 joint publications
Jean-Jacques Grob
2 joint publications
James Larkin
2 joint publications
Ganessan Kichenadasse
